Clinical Trial Update: Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating apatinib as maintenance therapy in advanced lung adenocarcinoma; status not specified in the provided snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Lung Adenocarcinoma | Phase 2 | Status: UNKNOWN